» Articles » PMID: 36051128

Myotonic Dystrophy Type 1 Presenting with Dyspnea: A Case Report

Overview
Specialty General Medicine
Date 2022 Sep 2
PMID 36051128
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Myotonic dystrophy type 1 (DM1) is a genetic neuromuscular disease involving multiple systems, especially the cardiopulmonary system. The clinical phenotype of DM1 patients is highly variable, which limits early diagnosis and treatment. In the present study, we reported a 35-year-old female DM1 patient with dyspnea as the primary onset clinical manifestation, analyzed her family's medical history, and reviewed related literature.

Case Summary: A 35-year-old woman was admitted to the hospital with dyspnea of 1 mo duration, and sleep apnea for 3 d. Her respiratory pattern and effort were normal, but limb muscle tension was low. Investigation into the patient's medical history revealed that she might have hereditary neuromuscular disease. Electromyography showed that her myotonia potentials were visible in the resting state of the examined muscles, with decreased motor unit potential time limit and amplitude. Genetic testing for DM1 revealed that the cytosine-thymine-guanine (CTG) repeat number of the gene exceeded 50, while cytosine-CTG expansion in intron 1 of gene was < 30 repeats. The patient was diagnosed with DM1.

Conclusion: DM1 is a genetic neuromuscular disease involving multiple systems, and the clinical phenotype in DM1 is extremely variable. Some patients with DM1 may be presented at the respiratory department because of dyspnea, which should be cautioned by the pulmonologists. There may be no obvious or specific symptoms in the early stage of disease, and clinicians should improve their understanding of DM1 and make an early diagnosis, which will improve patients' quality of life.

Citing Articles

Late-Onset Proximal Myotonic Myopathy (PROMM): A Rare Presentation in an Adult.

Deolikar V, Saboo K, Kumar S, Acharya S, Chavan S Cureus. 2024; 15(12):e50711.

PMID: 38234939 PMC: 10794013. DOI: 10.7759/cureus.50711.

References
1.
Nguyen C, Campbell C . Myotonic dystrophy type 1. CMAJ. 2016; 188(14):1033. PMC: 5047820. DOI: 10.1503/cmaj.151384. View

2.
Tzeng A, Bach J . Prevention of pulmonary morbidity for patients with neuromuscular disease. Chest. 2000; 118(5):1390-6. DOI: 10.1378/chest.118.5.1390. View

3.
Rossi S, Della Marca G, Ricci M, Perna A, Nicoletti T, Brunetti V . Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study. J Neurol Sci. 2019; 399:118-124. DOI: 10.1016/j.jns.2019.02.012. View

4.
Monteiro R, Bento J, Goncalves M, Pinto T, Winck J . Genetics correlates with lung function and nocturnal ventilation in myotonic dystrophy. Sleep Breath. 2013; 17(3):1087-92. DOI: 10.1007/s11325-013-0807-6. View

5.
Reardon W, Newcombe R, Fenton I, Sibert J, Harper P . The natural history of congenital myotonic dystrophy: mortality and long term clinical aspects. Arch Dis Child. 1993; 68(2):177-81. PMC: 1029229. DOI: 10.1136/adc.68.2.177. View